Cost-effectiveness of community health worker versus home-based guardians for directly observed treatment of tuberculosis in Vitória, Espírito Santo State, Brazil;Custo-efetividade dos agentes comunitários de saúde versus supervisores domiciliares na realização do tratamento supervisionado da tuberculose, Vitória, Espírito Santo, Brasil

Cadernos de Saude Publica

Volumn 27, Issue 5, 2011, Pages 944-952

  do Prado, Thiago Nascimento ^a   Wada, Nikolas ^b   Guidoni, Leticia Molino ^a   Golub, Jonathan E ^b   Dietze, Reynaldo ^a   Noia Maciel, Ethel Leonor ^a  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Cost benefit analysis; Effectiveness; Tuberculosis

Indexed keywords

ADULT; ARTICLE; BRAZIL; COMMUNITY CARE; COST BENEFIT ANALYSIS; DIRECTLY OBSERVED THERAPY; ECONOMICS; FEMALE; HEALTH AUXILIARY; HEALTH CARE COST; HEALTH CARE DISPARITY; HUMAN; LUNG TUBERCULOSIS; MALE;

ADULT; BRAZIL; COMMUNITY HEALTH AIDES; COMMUNITY HEALTH SERVICES; COST-BENEFIT ANALYSIS; DIRECTLY OBSERVED THERAPY; FEMALE; HEALTH CARE COSTS; HEALTH EXPENDITURES; HEALTHCARE DISPARITIES; HUMANS; MALE; TUBERCULOSIS, PULMONARY;

EID: 79958707699     PISSN: 0102311X     EISSN: 16784464     Source Type: Journal    
DOI: 10.1590/S0102-311X2011000500012     Document Type: Article

References (30)

1. World Health Organization. Global tuberculosis control: surveillance, planning, financing. WHO Report 2006. Geneva: World Health Organization; 2006.
2. Hopewell PC, Pai M, Maher D, Uplekar M, Raviglione MC. International standards for tuberculosis care. Lancet Infect Dis 2006; 6:710-25.
3. Okanurak K, Kitayaporn D, Wanarangsikul W, Koompong C. Effectiveness of DOT for tuberculosis treatment outcomes: a prospective cohort study in Bangkok, Thailand. Int J Tuberc Lung Dis 2007; 11:762-8.
4. Newell JN, Baral SC, Pande SB, Bam DS, Malla P. Family member DOTS and community DOTS for tuberculosis control in Nepal: cluster-randomised controlled trial. Lancet 2006; 367:903-9.
5. Maciel ELN, Silva AP, Meireles W, Fiorotti K, Hadad DJ, Dietze R. Tratamento Supervisionado em pacientes portadores de tuberculose utilizando supervisores domiciliares em Vitória, ES, Brasil. J Bras Pneumol 2008; 34:506-13.
6. Wilkinson D. High compliance tuberculosis treatment programme in a rural community. Lancet 1994; 343:647-8.
7. China Tuberculosis Control Programme. Results of directly observed short course chemotherapy in 112,842 Chinese patients with smear-positive tuberculosis. Lancet 1996; 347:358-62.
8. Chowdhury AMR, Chowdhury A, Islam MN, Vaughan JP. Control of tuberculosis by community health workers in Bangladesh. Lancet 1997; 350:169-72.
9. Stop TB Department. Community contribution to TB care: practice and policy. Geneva: World Health Organization; 2003. (WHO/CDS/TB/2003.312.).
10. Volmink J, Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev 2007; (4):CD003343.
11. Kamolratanakul P, Sawert H, Lertmaharit S, Kasetjaroen Y, Akksilp S, Tulaporn C, et al. Randomized controlled trial of directly observed treatment (DOT) for patients with pulmonary tuberculosis in Thailand. Trans R Soc Trop Med Hyg 1999; 93:552-7.
12. Zwarenstein M, Schoeman J, Vundule C, Lombard C, Tatley M. Randomised controlled trial of selfsupervised and directly observed treatment of tuberculosis. Lancet 1998; 352:1340-3.
13. Walley J, Khan A, Newell J, Khan H. Effectiveness of direct observation component of DOTS for tuberculosis: a randomised controlled trial in Pakistan. Lancet 2001; 357:664-9.
14. Khan MA, Walley J, Witter SN, Imran A, Safdar N. Costs and cost effectiveness of different DOTS strategies for treatment of tuberculosis: economic results of a randomised controlled trial in Pakistan. Health Policy Plan 2002; 17:178-86.
15. Maciel EL, Guidoni LM, Brioshi AP, Prado TN, Fregona G, Hadad DJ, et al. Household members and health care workers as supervisors of tuberculosis treatment. Rev Saúde Pública 2010; 44:339-43.
16. Akkslip S, Rasmithat S, Maher, Sawert H. Direct observation of tuberculosis treatment by supervised family members in Yosothorn Province, Thailand. Int J Tuberc Lung Dis 1999; 3:1061-5.
17. Wyss K, Kilima P, Lorenz N. Cost of tuberculosis for households and health care providers in Dar Es Salaam. Trop Med Int Health 2001; 6:60-8.
18. Lwilla F, Schellenberg D, Masanga H. Evaluation of efficacy of community-based vs institutionalbased direct observed short-course treatment for the control of tuberculosis in Kilombero district, Tanzania. Trop Med Int Health 2003; 8:204-10.
19. Wandwalo E, Kapalata N, Egwaga S, Morkve O. Effectiveness of community based directly observed treatment for tuberculosis in an urban setting in Tanzania: a randomised controlled trial. Int J Tuberc Lung Dis 2004; 8:1248-54.
20. Lwilla F, Schellenberg D, Masanja H, Acosta C, Galindo C, Aponte J, et al. Evaluation of efficacy of community based vs. Institutional based direct observed short course treatment for the control of tuberculosis in Kilombero district, Tanzania. Trop Med Int Health 2003; 8:204-10.
21. Nedham DM, Godfrey-Faussett P, Foster SD. Barriers to tuberculosis control in urban Zambia: the economic impact and burden on patients prior to diagnosis. Int J Tuberc Lung Dis 1998; 2:811-7.
22. Floyd K, Skeva J, Nyirenda T, Gausi F, Salaniponi F. Cost and cost-effectiveness of increased community and primary care facility involvelment in tuberculosis care in Lilongwe District, Malawi. Int J Tuberc Lung Dis 2003; 7(9 Suppl 1):S29-37.
23. Nganda B, Wangombe J, Floyd K, Kangangi J. Cost and cost-effectiveness of increased community and primary care facility involvement in tuberculosis care in Machakos District, Kenya. Int J Tuberc Lung Dis 2003; 7(9 Suppl 1):S14-20.
24. Ministério da Saúde. Programa Agentes Comunitários de Saúde. Brasília: Ministério da Saúde; 2001.
25. Ferraz L, Aerts DRGC. O cotidiano de trabalho do agente comunitário de saúde no PSF em Porto Alegre. Ciênc Saúde Coletiva 2005; 10:347-55.
26. World Health Organization. Guidelines for cost and cost effectiveness analysis of tuberculosis control. Geneva: World Health Organization; 2002.
27. Muennig P. Designing and conducting cost-effectiveness analysis in medicine and health care. San Francisco: John Wiley and Sons; 2002.
28. Murray CJM, DeJonghe E, Chum HJ, Nyangulu DS, Salomao A, Styblo K. Cost-effectiveness of chemotherapy for pulmonary TB in three sub-Saharan African countries. Lancet 1991; 338:1305-8.
29. World Bank. World Development Report 1993. Investing in health. New York: Oxford University Press; 1993.
30. Johannesson M, Karlsson G. The friction cost method: a comment. J Health Econ 1997; 16:249-55.